Indication
Salmonella infection
2 clinical trials
11 products
Clinical trial
A Phase IIa Observer-blind, Randomized, Controlled, Age-de-escalation, Single Center Interventional Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GVGH iNTS Vaccine Against S. Typhimurium and S. Enteritidis, in Adults, Children and Infants, Including Dose-finding in Infants, in AfricaStatus: Recruiting, Estimated PCD: 2026-04-27
Product
Pneumococcal vaccineProduct
Inactivated polio vaccineProduct
iNTS-GMMAProduct
MenACWYProduct
PlaceboProduct
DTPa-HBV-IPV+HibProduct
Pentavalent vaccineProduct
Measles and Rubella vaccineProduct
Yellow Fever vaccineProduct
INTS-GMMAClinical trial
The Development of a Non-typhoidal Salmonella Human Challenge Model: A Safety and Dose Escalation StudyStatus: Recruiting, Estimated PCD: 2024-09-30
Product
Salmonella Typhimurium